72.11.Z - Research and experimental development on biotechnology
47 - Retail trade, except motor vehicle retail
70.2 - Management consultancy activities
71.12 - Engineering activities and related technical consultancy
72.11 - Research and experimental development on biotechnology
72.2 - Research and experimental development on social sciences and humanities
74 - Other professional, scientific and technical activities
78 - Employment activities
82 - Office administrative, office support and other business support activities
85.59 - Other education n.e.c.
2021 | 2022 | 2023 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Profit (loss) on sale | 39,7 | -24,2 | -8,7 | 63,9 |
Gross profit (loss) | 37,3 | -30,9 | -8,8 | 71,7 |
EBITDA | 37,3 | -24,9 | -2,8 | 88,9 |
Short time liabilities | 99,9 | 87,5 | 72,4 | -17,2 |
Other operating costs | 2,4 | 7 | 0 | -100 |
Income tax | -∞ | |||
Equity capital | 340,5 | 329 | 319,7 | -2,8 |
Operating profit (EBIT) | 37,3 | -30,9 | -8,7 | 71,7 |
Assets | 440,4 | 417,7 | 392,1 | -6,1 |
Net profit (loss) | 31,3 | -30,9 | -8,9 | 71,1 |
Cash | 27,1 | 24,4 | 3,4 | -86,2 |
Liabilities and provisions for liabilities | 99,9 | 88,7 | 72,4 | -18,4 |
Net income from sale | 386,7 | 105,5 | 64,5 | -38,8 |
Working assets | 41,4 | 24,7 | 5,1 | -79,3 |
Other income costs | 0 | 0,2 | 0 | -98,9 |
Basic operational activity income | -∞ | |||
Depreciation | 0 | 6 | 6 | 0 |
% | % | % | p.p. | |
Profitability of capital | 9,2 | -9,4 | -2,8 | 6,6 |
Equity capital to total assets | 77,3 | 78,8 | 81,5 | 2,7 |
Gross profit margin | 9,7 | -29,3 | -13,6 | 15,7 |
EBITDA Margin | 9,7 | -23,6 | -4,3 | 19,3 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 94 | 303 | 409 | 106 |
Current financial liquidity indicator | 0.4145958721637726 | 0.28255754709243774 | 0.07067245990037918 | -0,2 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane